Cargando…
Antibody formation against SARS-CoV-2 in imatinib-treated COVID-19 patients
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The British Infection Association. Published by Elsevier Ltd.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8381632/ https://www.ncbi.nlm.nih.gov/pubmed/34437930 http://dx.doi.org/10.1016/j.jinf.2021.08.034 |
| _version_ | 1783741408804339712 |
|---|---|
| author | Morales-Ortega, Alejandro Farfán-Sedano, Ana Isabel Izquierdo-Martínez, Aida Llarena-Barroso, Cristina Jaenes-Barrios, Beatriz Mesa-Plaza, Nieves Toledano-Macías, María Soria Fernández-Llamazares, Guillermo Molina-Esteban, Laura García de Tena, Jaime Prieto-Menchero, Santiago Gonzalo-Pascua, Sonia San Martín-López, Juan Víctor Bernal-Bello, David |
| author_facet | Morales-Ortega, Alejandro Farfán-Sedano, Ana Isabel Izquierdo-Martínez, Aida Llarena-Barroso, Cristina Jaenes-Barrios, Beatriz Mesa-Plaza, Nieves Toledano-Macías, María Soria Fernández-Llamazares, Guillermo Molina-Esteban, Laura García de Tena, Jaime Prieto-Menchero, Santiago Gonzalo-Pascua, Sonia San Martín-López, Juan Víctor Bernal-Bello, David |
| author_sort | Morales-Ortega, Alejandro |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8381632 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | The British Infection Association. Published by Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-83816322021-08-23 Antibody formation against SARS-CoV-2 in imatinib-treated COVID-19 patients Morales-Ortega, Alejandro Farfán-Sedano, Ana Isabel Izquierdo-Martínez, Aida Llarena-Barroso, Cristina Jaenes-Barrios, Beatriz Mesa-Plaza, Nieves Toledano-Macías, María Soria Fernández-Llamazares, Guillermo Molina-Esteban, Laura García de Tena, Jaime Prieto-Menchero, Santiago Gonzalo-Pascua, Sonia San Martín-López, Juan Víctor Bernal-Bello, David J Infect Letter to the Editor The British Infection Association. Published by Elsevier Ltd. 2022-02 2021-08-23 /pmc/articles/PMC8381632/ /pubmed/34437930 http://dx.doi.org/10.1016/j.jinf.2021.08.034 Text en © 2021 The British Infection Association. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Morales-Ortega, Alejandro Farfán-Sedano, Ana Isabel Izquierdo-Martínez, Aida Llarena-Barroso, Cristina Jaenes-Barrios, Beatriz Mesa-Plaza, Nieves Toledano-Macías, María Soria Fernández-Llamazares, Guillermo Molina-Esteban, Laura García de Tena, Jaime Prieto-Menchero, Santiago Gonzalo-Pascua, Sonia San Martín-López, Juan Víctor Bernal-Bello, David Antibody formation against SARS-CoV-2 in imatinib-treated COVID-19 patients |
| title | Antibody formation against SARS-CoV-2 in imatinib-treated COVID-19 patients |
| title_full | Antibody formation against SARS-CoV-2 in imatinib-treated COVID-19 patients |
| title_fullStr | Antibody formation against SARS-CoV-2 in imatinib-treated COVID-19 patients |
| title_full_unstemmed | Antibody formation against SARS-CoV-2 in imatinib-treated COVID-19 patients |
| title_short | Antibody formation against SARS-CoV-2 in imatinib-treated COVID-19 patients |
| title_sort | antibody formation against sars-cov-2 in imatinib-treated covid-19 patients |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8381632/ https://www.ncbi.nlm.nih.gov/pubmed/34437930 http://dx.doi.org/10.1016/j.jinf.2021.08.034 |
| work_keys_str_mv | AT moralesortegaalejandro antibodyformationagainstsarscov2inimatinibtreatedcovid19patients AT farfansedanoanaisabel antibodyformationagainstsarscov2inimatinibtreatedcovid19patients AT izquierdomartinezaida antibodyformationagainstsarscov2inimatinibtreatedcovid19patients AT llarenabarrosocristina antibodyformationagainstsarscov2inimatinibtreatedcovid19patients AT jaenesbarriosbeatriz antibodyformationagainstsarscov2inimatinibtreatedcovid19patients AT mesaplazanieves antibodyformationagainstsarscov2inimatinibtreatedcovid19patients AT toledanomaciasmaria antibodyformationagainstsarscov2inimatinibtreatedcovid19patients AT soriafernandezllamazaresguillermo antibodyformationagainstsarscov2inimatinibtreatedcovid19patients AT molinaestebanlaura antibodyformationagainstsarscov2inimatinibtreatedcovid19patients AT garciadetenajaime antibodyformationagainstsarscov2inimatinibtreatedcovid19patients AT prietomencherosantiago antibodyformationagainstsarscov2inimatinibtreatedcovid19patients AT gonzalopascuasonia antibodyformationagainstsarscov2inimatinibtreatedcovid19patients AT sanmartinlopezjuanvictor antibodyformationagainstsarscov2inimatinibtreatedcovid19patients AT bernalbellodavid antibodyformationagainstsarscov2inimatinibtreatedcovid19patients |